D-0444-2023 Class II Terminated

Recalled by Denver Solutions, LLC DBA Leiters Health — Englewood, CO

FDA drug recall D-0444-2023 was initiated by Denver Solutions, LLC DBA Leiters Health on Feb 21, 2023 and is designated Class II. Reason for recall: CGMP DEVIATIONS The recall status is terminated (terminated Jan 11, 2024). Affected quantity: 1212 units.

Recall details

Product Type
Drugs
Report Date
Mar 15, 2023
Initiation Date
Feb 21, 2023
Termination Date
Jan 11, 2024
Voluntary/Mandated
Voluntary: Firm initiated
Product Quantity
1212 units

Product description

Phenylephrine HCl 40 mg (160 mcg/mL) added to 0.9% Sodium Chloride 250 mL IV Bag, Leiter Compounding Health 13796 Compark Blvd Englewood CO 80112, NDC 71449-150-82

Reason for recall

CGMP DEVIATIONS

Distribution pattern

Nationwide within the United States including VA or other Government facilities

Code information

Lot #: 2231017, Exp. Date 3/12/2023

Source

Dataset
openFDA drug recall enforcement reports
FDA record
This recall in openFDA (JSON)
Enforcement Report
Search FDA's Enforcement Report for D-0444-2023
openFDA file date
Nov 10, 2026
Loaded by RegDataLab
Nov 11, 2026

These dates say when openFDA published the data file and when RegDataLab last loaded it.

Source: openFDA record for D-0444-2023. Report a data issue: hello@regdatalab.com.